logo
calendar2 феврал 2020
view2
Asosiy til:Ingliz

ARTERIAL GIPERTENZIYA FARMAKOTERAPIYASINING AYRIM MUAMMOLARI: TIBBIY TAVSIYALARNI BAJARISH VA DORI VOSITALARNI TANLASH

Fan yo'nalishi:
pdf

5e36482a5504e.pdf

PDF

MAQOLA ANNOTATSIYASI

quote
Antihipertensif dori-darmonlarni qabul qilish bo'yicha bemorlarning tibbiy tavsiyalarini bajarish bo'yicha ma'lumotlar keltirilgan. Shu bilanbirga, arterial hipertensiyani davolash uchun vrachlar tomonidan tavsiya etilgan antihipertensif dorilar tahlil qilindi. Arterial hipertensiyaga uchragan bemorlar orasida antihipertensif dorilar etarli darajada foydalanish bilan bog'liq salbiy holat borligi ko'rsatilgan. Shu bilanbirga, arterial hipertensiyabilanog'riganbemorlarningfaqat 40% antihipertensif dorilarni muntazam ravishda qabul qilishadi. Olingan ma'lumotlarga ko'ra, shifokorlar beta-blokatorlarni ko'proq tavsiya qilishadi.

MUALIFLAR

Teglar

# фармакотерапия# pharmacotherapy# артериальная гипертензия# Arterial hypertension# arterial gipertenziya# implementation of medical recomm# choice of antihypertensive medic# farmakoterapiya# tibbiy tavsiyalarni bajarish# antihipertensifdorilarni tanlash# выполнение врачебных рекомендаци# выбор антигипертензивного лекарс

Maqolani baholang

0

0 ta

Maqola idintifikatorlari

Foydalanilgan adabiyotlar

1. OdutayoA, WongCX, HsiaoAJ, etal. Atrial fbrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016;354:i4482 10.1136/bmj.i4482

2. Mente A, O’Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet 2016;388:465–75. 10.1016/S0140- 6736(16)30467-6

3. Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular fltration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 2015;3:514–25. 10.1016/ S2213-8587(15)00040-6

4. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–44. 10.2337/diacare.16.2.434

5.Kayumov U.K., Kalandarova U.A., Ibadova M.U., Ismatova M.N.The formation of a hard «end points» for various risk factors. Journal of Biomedicine and Practice, 2019, vol. 1, issue 1, pp.80–85. https://www.tadqiqot.uz/wp-content/uploads/2019/05/ biomedicine-2019-1/biomedicine-2019-01.pdf http://dx.doi.org/10.26739/2181-9297-2019-1-14.

6. Hao Wang, Ying Ba, Run-Ce Cai, and Qian Xing. Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies. BMJ Open. 2019; 9(7): e024935. Published online 2019 Jul 17. doi: 10.1136/bmjopen-2018-024935. https://europepmc.org/articles/ pmc6661591#fragment-fulltext

7. Каюмов У.К. Изучение некоторых внутренних болезней при метаболическом синдроме и различных категориях гипергликемии. Евразийский научный журнал. 2017. -№2. – С. 405-408. https://elibrary.ru/item.asp?id=28872542

8. Абдухакимова Н.А., Хатамова Д.Т., Каюмов У.К. Частота и уровни некоторых основных компонентов метаболического синдрома у больных подагрой при сахарном диабете и нарушенной толерантности к глюкозе. Врачаспирант. - 2009. - №3. – С. 182-183. http://www.wisesoft.ru/load4317.htm

9. Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., E. Grobbee D., Jaarsma T., Kirchhof P., E. Kjeldsen S., Laurent S., J. Manolis A., M. Nilsson P., Miguel Ruilope L., E. Schmieder R., Sirnes P., Sleight P., Viigimaa M., Waeber B., Zannad F. 2013 ESH/ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION. Russian Journal of Cardiology. 2014;(1):7-94. https://doi. org/10.15829/1560-4071-2014-1-7-94.

public

SLIB.uz — O'zbekiston ilmiy jurnallari va maqolalar yagona tizimda ilmiy nashirlarni bir joyda ko'rish, izlash va ulardan foydalanish imkonini beruvchi zamonaviy platforma.

Ijtimoiy tarmoqlarda
instagramtelegramyoutubefacebook

Bog'lanish uchun

Manzil:Chilonzor tumani Qatortol ko'chasi 60B

Tel:+998(55)511-44-00

Savol-javob va takliflar uchun

© 2026 Barcha huquqlar himoyalangan.